Sign in
CompletedPhase 3

A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Key facts

Who runs it
Beijing Suncadia Pharmaceuticals Co., Ltd
Where
China2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
1,165 people enrolled
Started
16 Mar 2025
Ended
23 Apr 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • SHR-2004 injection
  • Enoxaparin sodium injection
  • Enoxaparin sodium injection placebo
  • SHR-2004 placebo
Record updated
28 August 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Understand the research procedures and methods, volunteer to participate in this trial, and sign the informed consent form in writing
  • Planned elective schedule total knee arthroplasty (TKA) patients
  • Men or women who are ≥ 18 years old and < 80 years old on the day of signing the informed consent form

Who cannot take part

  • Malignant tumor within one year of the screening
  • Myocardial infarction, transient ischemic attack or ischemic stroke occurred within 6 months of the screening
  • Any medical history that may increase the risk of bleeding or any conditions that the investigator considers to increase the risk of bleeding
  • History of drug abuse
  • Unable to receive CT angiography of both lower limbs
  • Pregnant or lactating women

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of the study is to evaluate the efficacy and safety of SHR-2004 in preventing venous thromboembolism after elective unilateral total knee arthroplasty.

The 3 groups in the trial

  • Group ATreatment being tested

    Treatment: SHR-2004 injection, Enoxaparin sodium injection placebo, and SHR-2004 placebo

  • Group BTreatment being tested

    Treatment: SHR-2004 injection, Enoxaparin sodium injection placebo, and SHR-2004 placebo

  • Group CExisting treatment, for comparison

    Treatment: Enoxaparin sodium injection and SHR-2004 placebo

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter, Randomized, Double-blind, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Arthroplasty
Record updated
28 August 2026